Verbrugge S J, Vazquez de Anda G, Gommers D, Neggers S J, Sorm V, Böhm S H, Lachmann B
Department of Anesthesiology, Erasmus University Rotterdam, The Netherlands.
Anesthesiology. 1998 Aug;89(2):467-74. doi: 10.1097/00000542-199808000-00024.
Changes in pulmonary edema infiltration and surfactant after intermittent positive pressure ventilation with high peak inspiratory lung volumes have been well described. To further elucidate the role of surfactant changes, the authors tested the effect of different doses of exogenous surfactant preceding high peak inspiratory lung volumes on lung function and lung permeability.
Five groups of Sprague-Dawley rats (n = 6 per group) were subjected to 20 min of high peak inspiratory lung volumes. Before high peak inspiratory lung volumes, four of these groups received intratracheal administration of saline or 50, 100, or 200 mg/kg body weight surfactant; one group received no intratracheal administration. Gas exchange was measured during mechanical ventilation. A sixth group served as nontreated, nonventilated controls. After death, all lungs were excised, and static pressure-volume curves and total lung volume at a transpulmonary pressure of 5 cm H2O were recorded. The Gruenwald index and the steepest part of the compliance curve (Cmax) were calculated. A bronchoalveolar lavage was performed; surfactant small and large aggregate total phosphorus and minimal surface tension were measured. In a second experiment in five groups of rats (n = 6 per group), lung permeability for Evans blue dye was measured. Before 20 min of high peak inspiratory lung volumes, three groups received intratracheal administration of 100, 200, or 400 mg/ kg body weight surfactant; one group received no intratracheal administration. A fifth group served as nontreated, nonventilated controls.
Exogenous surfactant at a dose of 200 mg/kg preserved total lung volume at a pressure of 5 cm H2O, maximum compliance, the Gruenwald Index, and oxygenation after 20 min of mechanical ventilation. The most active surfactant was recovered in the group that received 200 mg/kg surfactant, and this dose reduced minimal surface tension of bronchoalveolar lavage to control values. Alveolar influx of Evans blue dye was reduced in the groups that received 200 and 400 mg/kg exogenous surfactant.
Exogenous surfactant preceding high peak inspiratory lung volumes prevents impairment of oxygenation, lung mechanics, and minimal surface tension of bronchoalveolar lavage fluid and reduces alveolar influx of Evans blue dye. These data indicate that surfactant has a beneficial effect on ventilation-induced lung injury.
高吸气峰肺容积间歇性正压通气后肺水肿浸润和表面活性物质的变化已有详尽描述。为进一步阐明表面活性物质变化的作用,作者测试了在高吸气峰肺容积之前给予不同剂量外源性表面活性物质对肺功能和肺通透性的影响。
将五组Sprague-Dawley大鼠(每组n = 6)进行20分钟的高吸气峰肺容积通气。在高吸气峰肺容积通气前,其中四组经气管内给予生理盐水或50、100或200mg/kg体重的表面活性物质;一组未进行气管内给药。在机械通气期间测量气体交换。第六组作为未处理、未通气的对照组。处死大鼠后,切除所有肺脏,记录静态压力-容积曲线以及跨肺压为5cm H₂O时的肺总量。计算格伦瓦尔德指数和顺应性曲线最陡部分(Cmax)。进行支气管肺泡灌洗;测量表面活性物质小聚集体和大聚集体的总磷以及最小表面张力。在另一项对五组大鼠(每组n = 6)进行的实验中,测量伊文思蓝染料的肺通透性。在20分钟高吸气峰肺容积通气前,三组经气管内给予100、200或400mg/kg体重的表面活性物质;一组未进行气管内给药。第五组作为未处理、未通气的对照组。
200mg/kg剂量的外源性表面活性物质在机械通气20分钟后可维持5cm H₂O压力下的肺总量、最大顺应性、格伦瓦尔德指数和氧合。在接受200mg/kg表面活性物质的组中回收的表面活性物质活性最高,该剂量可将支气管肺泡灌洗的最小表面张力降至对照值。接受200和400mg/kg外源性表面活性物质的组中伊文思蓝染料的肺泡内流减少。
在高吸气峰肺容积之前给予外源性表面活性物质可预防氧合受损、肺力学改变以及支气管肺泡灌洗液体最小表面张力的变化,并减少伊文思蓝染料的肺泡内流。这些数据表明表面活性物质对通气诱导的肺损伤具有有益作用。